Healthcare -
Biotechnology - NASDAQ - US
$ 2.751
14.6 %
$ 132 M
Market Cap
-1.99
P/E
SAVA - TOTAL EQUITY
Total Equity SAVA - Cassava Sciences, Inc.
137 M
LAST VALUE
-26.42%
2 YEAR CAGR
47.59%
5 YEAR CAGR
11.03%
10 YEAR CAGR